- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Hepatitis A Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 813.9 million in 2021 and is forecast to a readjusted size of USD 935.5 million by 2028 with a CAGR of 2.0% during review period. Government Institution accounting for % of the Hepatitis A Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, and Zhejiang Pukang, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hepatitis A Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Vaccine
Live Attenuated Vaccine
Market segment by Application can be divided into
Government Institution
Private Sector
Other
The key market players for global Hepatitis A Vaccine market are listed below:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis A Vaccine, with price, sales, revenue and global market share of Hepatitis A Vaccine from 2019 to 2022.
Chapter 3, the Hepatitis A Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hepatitis A Vaccine.
Chapter 13, 14, and 15, to describe Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Hepatitis A Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepatitis A Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepatitis A Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A Vaccine Market Size & Forecast
1.4.1 Global Hepatitis A Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hepatitis A Vaccine Sales in Volume (2017-2028)
1.4.3 Global Hepatitis A Vaccine Price (2017-2028)
1.5 Global Hepatitis A Vaccine Production Capacity Analysis
1.5.1 Global Hepatitis A Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Hepatitis A Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepatitis A Vaccine Market Drivers
1.6.2 Hepatitis A Vaccine Market Restraints
1.6.3 Hepatitis A Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Hepatitis A Vaccine Product and Services
2.1.4 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Hepatitis A Vaccine Product and Services
2.2.4 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Hepatitis A Vaccine Product and Services
2.3.4 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Hepatitis A Vaccine Product and Services
2.4.4 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Hepatitis A Vaccine Product and Services
2.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product and Services
2.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Hepatitis A Vaccine Product and Services
2.7.4 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IMBCA
2.8.1 IMBCA Details
2.8.2 IMBCA Major Business
2.8.3 IMBCA Hepatitis A Vaccine Product and Services
2.8.4 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ChangSheng
2.9.1 ChangSheng Details
2.9.2 ChangSheng Major Business
2.9.3 ChangSheng Hepatitis A Vaccine Product and Services
2.9.4 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Convac
2.10.1 Convac Details
2.10.2 Convac Major Business
2.10.3 Convac Hepatitis A Vaccine Product and Services
2.10.4 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hepatitis A Vaccine Breakdown Data by Manufacturer
3.1 Global Hepatitis A Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hepatitis A Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hepatitis A Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2021
3.5 Global Hepatitis A Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hepatitis A Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hepatitis A Vaccine Market Size by Region
4.1.1 Global Hepatitis A Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Hepatitis A Vaccine Revenue by Region (2017-2028)
4.2 North America Hepatitis A Vaccine Revenue (2017-2028)
4.3 Europe Hepatitis A Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Hepatitis A Vaccine Revenue (2017-2028)
4.5 South America Hepatitis A Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Hepatitis A Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hepatitis A Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Hepatitis A Vaccine Revenue by Type (2017-2028)
5.3 Global Hepatitis A Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hepatitis A Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Hepatitis A Vaccine Revenue by Application (2017-2028)
6.3 Global Hepatitis A Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hepatitis A Vaccine Sales by Type (2017-2028)
7.2 North America Hepatitis A Vaccine Sales by Application (2017-2028)
7.3 North America Hepatitis A Vaccine Market Size by Country
7.3.1 North America Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028)
8.2 Europe Hepatitis A Vaccine Sales by Application (2017-2028)
8.3 Europe Hepatitis A Vaccine Market Size by Country
8.3.1 Europe Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hepatitis A Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Hepatitis A Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Hepatitis A Vaccine Market Size by Region
9.3.1 Asia-Pacific Hepatitis A Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hepatitis A Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hepatitis A Vaccine Sales by Type (2017-2028)
10.2 South America Hepatitis A Vaccine Sales by Application (2017-2028)
10.3 South America Hepatitis A Vaccine Market Size by Country
10.3.1 South America Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hepatitis A Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Hepatitis A Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Hepatitis A Vaccine Market Size by Country
11.3.1 Middle East & Africa Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hepatitis A Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hepatitis A Vaccine
12.3 Hepatitis A Vaccine Production Process
12.4 Hepatitis A Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hepatitis A Vaccine Typical Distributors
13.3 Hepatitis A Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Hepatitis A Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hepatitis A Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Hepatitis A Vaccine Product and Services
Table 6. GSK Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Hepatitis A Vaccine Product and Services
Table 10. Merck Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Hepatitis A Vaccine Product and Services
Table 14. Sanofi Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sinovac Basic Information, Manufacturing Base and Competitors
Table 16. Sinovac Major Business
Table 17. Sinovac Hepatitis A Vaccine Product and Services
Table 18. Sinovac Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
Table 20. Zhejiang Pukang Major Business
Table 21. Zhejiang Pukang Hepatitis A Vaccine Product and Services
Table 22. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 24. Changchun Institute of Biological Major Business
Table 25. Changchun Institute of Biological Hepatitis A Vaccine Product and Services
Table 26. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 28. KM Biologics Major Business
Table 29. KM Biologics Hepatitis A Vaccine Product and Services
Table 30. KM Biologics Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. IMBCA Basic Information, Manufacturing Base and Competitors
Table 32. IMBCA Major Business
Table 33. IMBCA Hepatitis A Vaccine Product and Services
Table 34. IMBCA Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ChangSheng Basic Information, Manufacturing Base and Competitors
Table 36. ChangSheng Major Business
Table 37. ChangSheng Hepatitis A Vaccine Product and Services
Table 38. ChangSheng Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Convac Basic Information, Manufacturing Base and Competitors
Table 40. Convac Major Business
Table 41. Convac Hepatitis A Vaccine Product and Services
Table 42. Convac Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Hepatitis A Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Unit)
Table 44. Global Hepatitis A Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Hepatitis A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Hepatitis A Vaccine Production Capacity by Company, (K Unit): 2020 VS 2021
Table 47. Head Office and Hepatitis A Vaccine Production Site of Key Manufacturer
Table 48. Hepatitis A Vaccine New Entrant and Capacity Expansion Plans
Table 49. Hepatitis A Vaccine Mergers & Acquisitions in the Past Five Years
Table 50. Global Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
Table 51. Global Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
Table 52. Global Hepatitis A Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Hepatitis A Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
Table 55. Global Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
Table 56. Global Hepatitis A Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Hepatitis A Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Hepatitis A Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Hepatitis A Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
Table 61. Global Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
Table 62. Global Hepatitis A Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Hepatitis A Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Hepatitis A Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Hepatitis A Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
Table 67. North America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
Table 68. North America Hepatitis A Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Hepatitis A Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
Table 71. North America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
Table 72. North America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
Table 73. North America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
Table 74. Europe Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
Table 75. Europe Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
Table 76. Europe Hepatitis A Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Hepatitis A Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
Table 79. Europe Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
Table 80. Europe Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
Table 81. Europe Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
Table 82. Asia-Pacific Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
Table 83. Asia-Pacific Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
Table 84. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
Table 87. Asia-Pacific Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
Table 88. Asia-Pacific Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
Table 89. Asia-Pacific Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
Table 90. South America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
Table 91. South America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
Table 92. South America Hepatitis A Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Hepatitis A Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
Table 95. South America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
Table 96. South America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
Table 97. South America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
Table 98. Middle East & Africa Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
Table 99. Middle East & Africa Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
Table 100. Middle East & Africa Hepatitis A Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Hepatitis A Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
Table 103. Middle East & Africa Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
Table 104. Middle East & Africa Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
Table 105. Middle East & Africa Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
Table 106. Hepatitis A Vaccine Raw Material
Table 107. Key Manufacturers of Hepatitis A Vaccine Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Hepatitis A Vaccine Typical Distributors
Table 111. Hepatitis A Vaccine Typical Customers
List of Figures
Figure 1. Hepatitis A Vaccine Picture
Figure 2. Global Hepatitis A Vaccine Revenue Market Share by Type in 2021
Figure 3. Inactivated Vaccine
Figure 4. Live Attenuated Vaccine
Figure 5. Global Hepatitis A Vaccine Revenue Market Share by Application in 2021
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global Hepatitis A Vaccine Revenue, (USD Million) & (K Unit): 2017 & 2021 & 2028
Figure 10. Global Hepatitis A Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Hepatitis A Vaccine Sales (2017-2028) & (K Unit)
Figure 12. Global Hepatitis A Vaccine Price (2017-2028) & (USD/Unit)
Figure 13. Global Hepatitis A Vaccine Production Capacity (2017-2028) & (K Unit)
Figure 14. Global Hepatitis A Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Hepatitis A Vaccine Market Drivers
Figure 16. Hepatitis A Vaccine Market Restraints
Figure 17. Hepatitis A Vaccine Market Trends
Figure 18. Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Hepatitis A Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Hepatitis A Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Hepatitis A Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Hepatitis A Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Hepatitis A Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Hepatitis A Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Hepatitis A Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Hepatitis A Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Hepatitis A Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Hepatitis A Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Hepatitis A Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Hepatitis A Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Hepatitis A Vaccine
Figure 78. Hepatitis A Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
